why choose us

Clinical Trials Search

Showing 8,520 of 132,366 result(s)
Vibrotactile Coordinated Reset in Parkinson's Disease - Proof of Concept Study

Status: NOT_YET_RECRUITING

Condition: Parkinson Disease

Interventions: The non-invasive neuromodulation hardware system comprises two wireless controllers;battery packs which are fastened to the top of each hand via

Date: 2023-08-31

The Purpose of This Study is to Evaluate the Efficacy and Safety of Aficamten (CK-3773274) Compared to Placebo in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

Status: Completed

Condition: Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Interventions: Oral Tablet

Date: 2023-08-31

A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients

Status: Completed

Condition: Ovarian Carcinoma

Interventions: Sacituzumab govitecan will be administered at 10 mg;kg weekly as an infusion for 2 consecutive weeks (2 weekly doses plus 1 week without treatmen

Date: 2023-08-31

Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

Status: Completed

Condition: Allogeneic Hematopoietic Stem Cell Transplantation

Interventions: Given Day-5, Day-4, Day-3, Day-2

Date: 2023-08-31

CLN-617 Alone and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

Status: Completed

Condition: Advanced Solid Tumor

Interventions: Single-chain fusion protein comprised of human IL-2, human LAIR2, HSA, and human IL-12, connected via glycine;serine linker sequences

Date: 2023-08-31

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

Status: NOT_YET_RECRUITING

Condition: Advanced Solid Malignancies

Interventions: GIM-122 administered IV once every 3 weeks

Date: 2023-08-31

Study of RMC-9805 in Participants With KRASG12D-Mutant Solid Tumors

Status: Completed

Condition: Non-small Cell Lung Cancer (NSCLC)

Interventions: Oral Tablets

Date: 2023-08-31

A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Two Different Formulations of Long-acting Cabotegravir in Healthy Adult Participants

Status: NOT_YET_RECRUITING

Condition: HIV Infections

Interventions: Cabotegravir Formulation F will be administered

Date: 2023-08-31

A Study of Hemp Hull WFI for IBS Diarrhea

Status: Completed

Condition: Irritable Bowel Syndrome-bile Acid Diarrhea

Interventions: 20 grams minimally processed form of Hemp hulls in the form of a bar;wafer.

Date: 2023-08-31

Diclofenac as a KMO Inhibitor

Status: NOT_YET_RECRUITING

Condition: Alcohol Use Disorder

Interventions: 100 mg

Date: 2023-08-31